![]() Semma Therapeutics Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients. | ![]() InVivo Therapeutics InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. | ![]() Larimar Therapeutics Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders. | ![]() Oramed Pharmaceuticals Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies. | ![]() Kowa Pharmaceuticals America Kowa Pharmaceuticals America is a pharmaceutical company focused on cardiometabolic diseases. | |
Founding Date | Founding Date 2015 | Founding Date 2005 | Founding Date 2005 | Founding Date 2006 | Founding Date 2008 |
Type | Type Subsidiary | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | |||||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations Cambridge, US HQ | Locations Bala Cynwyd, US HQ | Locations New York, US HQ Jerusalem, IL | Locations Montgomery, US HQ |
Employees | Employees 88 | Employees 6 | Employees 782% decrease | Employees 1417% increase | Employees 3521% increase |
Valuation ($) | Valuation ($) N/A | Valuation ($) 995.9 k | Valuation ($) 496.4 m | Valuation ($) 94.2 m | Valuation ($) N/A |
Financial | |||||
Net income | Net income N/A | Net income ($10.5m) (FY, 2022) | Net income ($165.7m) (FY, 2025) | Net income $64m (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 163m | Total funding raised $ 75.2m | Total funding raised $ 132.2m | Total funding raised $ 1m | Total funding raised N/A |

InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focused on developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries.
View company
Larimar Therapeutics (formerly known as Zafgen) is a biopharmaceutical company dedicated to improving the health and well-being of patients affected by obesity and complex metabolic disorders.
View company
Oramed Pharmaceuticals is the developer of an innovative technology to transform injectable treatments into oral therapies.
View company
Kowa Pharmaceuticals America is a pharmaceutical company focused on cardiometabolic diseases.
View company